Clindamycin alone, however, does not appear to be effective in preventing relapse. Fansidar is a treatment alternative currently being evaluated in Europe. Fansidar received some bad press in the beginning of the epidemic because it has been related to severe skin reactions such as the Stevens-Johnson syndrome. The drug is now being looked at more closely because of promising study results in Europe. 566C80 is another drug being studied for use against toxoplasmosis.
Further studies are underway.
Implications for Future Therapeutic Trials. VI Conference on AIDS, San Francisco, June 1990. Regents of the University of California, San Francisco abstract Th.B476. J of Infect. Luft BJ, Remington JS, AIDS Commentary.